Team members
Researchers
Nathalie MIELCAREK, DR2 Inserm
Alain BAULARD, DR2 Inserm
Françoise JACOB-DUBUISSON, DR1 CNRS
Camille LOCHT, DRE Inserm
Philip SUPPLY, DRE CNRS
Rudy ANTOINE, CRCN Inserm
Stéphane CAUCHI, CRCN CNRS
Loïc COUTTE, CRCN Inserm
Carine ROUANET, CR IPL
Romain VEYRON-CHURLET, CRCN CNRS
Engineers and technicians
Anne-Sophie DEBRIE IE IPL
Baptiste KUCHARSKI, IE CDD
Sophie LECHER, AR IPL
Stéphanie SLUPEK, AR IPL
Morgane TARDY, AI
PostDocs, PhDs and M2 students
Zainab EDOO, PostDoc
Rim GHARBI, PostDoc
Camille GROSSE, PostDoc
Kamila RUIS SANTOS, PostDoc
Elena SANTIESTEBAN, PostDoc
Guillaume CAMUS, PhD Student
Majda HACHMI, PhD Student
Laura LEPREVOST, PhD Student
Dacine OSMANI, PhD Student
Oriane RIVIERE, PhD Student
Former PhDs - Post Docs
Salam Al Ashkar (2016-2019), Université de Lille II
Fellowship: Association AZM and Saadeh
Title: Prevalence of drug-resistant tuberculosis assessed by next-generation sequencing: an 18-month nationwide study in Lebanon
Supervisor: P. Supply
Current employment: Application and communication scientist specialist, LABPLAS, Montreal, Canada
Elian Dupré (2009-2013), Université de Lille II
Fellowship: French Research Ministry for 3 years and FRM for the 4th
Title: Virulence regulation in Bordetella pertussis : BvgS, an original model for a two-component system receptor
Supervisor: F. Jacob-Dubuisson
Current employment: post-doctoral fellow, University of Lille 1
Jérémy Guérin (2011-2014), Université de Lille II
Fellowship: Institut Pasteur of Lille/ Région Nord-Pas de Calais.
Title: Conformationnal dynamics of FhaC, the transporter across the outer membrane of the filamentous hemaggutinin in Bordetella pertussis
Supervisor: F. Jacob-Dubuisson
Current employment: post-doctoral fellow, NIH, USA
Elodie Lesne (2013-2016), Université de Lille II
Fellowship: INSERM/ Région Nord-Pas de Calais.
Title: Virulence regulation by the whooping cough agent Bordetella pertussis : signaling by the sensor-kinase BvgS
Supervisor: F. Jacob-Dubuisson
Current employment: scientist at Public Health England, Porton Down, Salisbury, UK
Marion Prieri (2015-2018), Université de Lille
Fellowship: Institut Pasteur de Lille/ Région Haut de France
Title: Reprogramming the anti-TB pro-drugs: design, development and biological evaluation of inhibitors of transcriptional regulators
Co-SupervisorS: Alain Baulard / Nicolas Willand
Current employment: Newcastle University, Newcastle-upon-Tyne, UK
Alex Rivera (2016-2020), Université de Lille
Fellowship: University of Lille/Region Hauts de France
Title: Copper homeostasis in Bordetella pertussis and its relationship with virulence
Supervisor: F. Jacob-Dubuisson and Rudy Antoine
Current employment: post-doctoral fellow, Institut National de la Recherche Scientifique | INRS · Institute Armand-Frappier, Québec
Gauthier Roy (2018-2022) Université de Lille
Fellowship: Université de Lille
Title: Characterization of a new copper transport system in B; pertussis: mode of action and regulation
Supervisor: F. Jacob-Dubuisson and Rudy Antoine
Anaïs Thiriard (2016-2019), Université de Lille
Fellowship: Institut Pasteur de Lille
Title : Study on the functionality of anti-pertussis antibodies
Supervisor: Camille Locht
Current employment: post-doctoral fellow, University of Lille 1
Catherine Baud (France), from 2010 to 2014
Financial support: ANR grant DYN FHAC
Thomas Belcher (UK), from 2017 to 2020
Financial supports: CPER CTRL IPL
Violaine Dubois (France), from 2019-2022
Financial supports: EU grant Periscope and ILiAD
Elian Dupré (France), from 2013 to 2016
Financial support: ANR grant MECA VENUS
Rosangela-Maria Frita (Portugal), from 2015 to 2021
Financial supports: Bioversys
Jeremy Guerin (France), 2015
Financial support: ANR grant DYN FHAC
Hannah Kammoun (Tunisia), oct. 2012 to Dec. 2013
Financial support: FP7 NewTBVac
Raphaella Iantomasi 2015-2016
Financial support: Lille European Metropolitan (MEL)
Martin Moune (Cameroon/France), from 2014 to 2017
Financial supports: PRIM (2014-2016) and GSK-Bioversys industrial partnership (2016-2018)
Luis Solans (Spain), from 2015 to January 31st, 2018
Financial supports: ILIAD Biotechnologies (industrial support)